Danish multicenter randomized study of invasive versus conservative treatment in patients with inducible ischemia after thrombolysis in acute myocardial infarction (DANAMI)

Circulation

Volumn 96, Issue 3, 1997, Pages 748-755

  Madsen, Jan K ^a   Grande, Peer ^a   Saunamäki, Kari ^a   Thayssen, Per ^a   Kassis, Eli ^a   Eriksen, Ulrik ^a   Rasmussen, Klaus ^a   Haunsø, Stig ^a   Nielsen, Torsten T ^a   Haghfelt, Torben ^a   Fritz Hansen, Per ^a   Hjelms, Erik ^a   Paulsen, Peter K ^a   Alstrup, Poul ^a   Arendrup, Henrik ^a   Niebuhr Jørgensen, Uffe ^a   Andersen, Lars I ^a  

^a Rigshospitalet   (Denmark)

Author keywords

Angioplasty; Bypass; Ischemia; Myocardial infarction; Revascularization

Indexed keywords

ALTEPLASE; ANISTREPLASE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; FIBRINOLYTIC AGENT; NITRIC ACID DERIVATIVE; STREPTOKINASE;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL TRIAL; CONSERVATIVE TREATMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DENMARK; EXERCISE TEST; FEMALE; FIBRINOLYTIC THERAPY; FOLLOW UP; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HEART REINFARCTION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TRANSLUMINAL CORONARY ANGIOPLASTY; UNSTABLE ANGINA PECTORIS;

EID: 0030797090     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.3.748     Document Type: Article

References (23)

1. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomized trials of more than 1000 patients. Lancet. 1994;343:311-322.
2. Lenderick T, Simoons ML, Van Es G-A, Van de Werf F, Verstrate M, Arnold AER. Benefit of thrombolytic therapy is sustained throughout five years and is related to TIMI perfusion grade 3 but not grade 2 flow at discharge. Circulation. 1995;92:1110-1116.
3. Van de Werf F, Arnold AER, for the European Cooperative Study Group for Recombinant Tissue Type Plasminogen Activator. Intravenous tissue plasminogen activator and size of infarct, left ventricular function and survival in acute myocardial infarction. Br Med J. 1988;297:1374-1379.
4. Simoons ML, Serruys PW, vd Brand M, Bärs F, De Zwaan C, Res J, Verbeugt FWA, Krauss XH, Remme WJ, Vermeer F, Lubsen J. Improved survival after early thrombolysis in acute myocardial infarction. Lancet. 1985;2:578-582.
5. Serruys PW, Wijns W, Simoons ML, Suryapranata H, Planellas J, van Domburg R, Fioretti P, De Feyter PJ, vd Brand M, Hugenholtz PG. Effect of intracoronary thrombolytic therapy on left ventricular function and mortality in patients with acute myocardial infarction: preliminary results of the Thoraxcenter randomised trial. Eur Heart J. 1985;6(suppl E):205-215.
6. Simoons ML, Arnold AER, Betriu A, de Bono DP, Col J, Dougherty FC, von Essen R, Lambertz H, Lubsen J, Meier B, Michel PL, Raynaud P, Rutsch W, Sanz GA, Schmidt W, Serruys PW, Thery C, Uebis R, Vahanian A, Van de Werf F, Willems GM, Wood D, Verstraete M. Thrombolysis with tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate percutaneous coronary angioplasty. Lancet. 1988;1: 197-203.
7. Topol E, Califf RM, George BS, Kereiakes DJ, Abbottsmith CW, Candela RJ, Lee KL, Pitt B, Stack RS, O'Neill WW, and the Thrombolysis and Angioplasty in Myocardial Infarction Study Group. A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. N Engl J Med. 1987;387:581-588.
8. The Veterans Administrations Coronary Artery Bypass Surgery Study Group. Eleven-year survival in the Veterans Administration randomized trial of coronary bypass surgery for stable angina. N Engl J Med. 1984;311:1333-1339.
9. Varnauskas E, Olsson SB, Carlstrom E, Karlsson T, Talwar KK, Julian DG, Miller HC, Oliver MF, Lorimer AR, Hutton I, Murray RG, Tweddel A, Lawrie T, Bain W, Caves P, Wheatly D, Frick MH, Harjola PT, Valle M, and the European Coronary Surgery Study Group. Twelve-year follow-up of survival in the randomized European Coronary Surgery Study. N Engl J Med. 1988;319: 332-337.
10. Rogers WJ, Bourassa MG, Andrews TC, Bertolet BD, Blumenthal RS, Chaitman BR, Forman SA, Geller NL, Goldberg AD, Habib GB, Masters RG, Moisa RB, Mueller H, Pearce DJ, Pepine CJ, Sopko G, Steingart RM, Stone PH, Knatterud GL, Conti CR, for the ACIP Investigators. Asymptomatic Cardiac Ischemia Pilot (ACIP) Study: outcome at 1 year for patients with asymptomatic cardiac ischemia randomized to medical therapy or revascularization. J Am Coll Cardiol. 1995;26:594-605.
11. The TIMI Study Group. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction: results of the Thrombolysis In Myocardial Infarction (TIMI) phase II trial. N Engl J Med. 1989;320:618-627.
12. SWIFT (Should We Intervene Following Thrombolysis?) Trial Study Group. SWIFT trial of delayed elective intervention versus conservative treatment after thrombolysis with anistreplase in acute myocardial infarction. Br Med J. 1991;302:555-560.
13. Barbash GL, Roth A, Hod H, Modan M, Miller HI, Rath S, Zahav YH, Keren G, Motro M, Shachar A, Basan S, Agranat O, Rabinowitz B, Laniado S, Kaplinsky E. Randomized controlled trial of late in-hospital angiography and angioplasty versus conservative management after treatment with recombinant tissue-type plasminogen activator in acute myocardial infarction. Am J Cardiol. 1990; 66:538-545.
14. Hindman NB, Schocken DD, Wichmann M, Anderson WD, White RD, Leggett S, Ideker RE, Hinohara T, Selvester RH, Wagner GS. Evaluation of a QRS scoring system for estimating myocardial infarct size: specificity and method of application of the complete system. Am J Cardiol. 1985;55:1485-1490.
15. Gill JB, Cairns JA, Roberts RS, Constatini L, Sealey BJ, Fallen EF, Tomlinson CW, Gent M. Prognostic importance of myocardial ischemia detected by ambulatory monitoring early after acute myocardial infarction. N Engl J Med. 1996;334:65-70.
16. Curtis JJ, Walls JT, Salam NH, Boley TM, Nawarawong W, Schmaltz RA, Landrenean RJ, Madsen R. Impact of unstable angina on operative mortality with coronary revascularization at varying time intervals after myocardial infarction. J Thorac Cardiovasc Surg. 1991;102:867-873.
17. O'Neill WW, Weintraub R, Grines CL, Meany TB, Brodie BR, Friedman HZ, Ramos RG, Gangadharan V, Lein RN, Choksi N, Strzelecki M, Timmis GC. A prospective, placebo-controlled, randomized trial of intravenous streptokinase and angioplasty versus lone angioplasty therapy of acute myocardial infarction. Circulation. 1992;86:1710-1717.
18. Fox JP, Beattie JM, Salih MM, Davies MK, Littler WA, Murray RG. Silent ischemia following myocardial infarction: frequency, characteristics and prognosis. Eur Heart J. 1988;suppl N:108-113.
19. Villella A, Maggioni AP, Villella M, Giordano A, Turazza FM, Santori E, Franzosi MG, on behalf of the GISSI-2 Investigators. Prognostic significance of maximal exercise testing after myocardial infarction treated with thrombolytic agents: the GISSI-2 data-base. Lancet. 1995;346:523-529.
20. Mueller HS, Forman SA, Menegus MA, Cohen LS, Knatterud GL, Braunwald E. Prognostic significance of nonfatal reinfarction during 3-year follow-up: results of the Thrombolysis In Myocardial Infarction (TIMI) phase II clinical trial. J Am Coll Cardiol. 1995; 26:900-907.
21. The Danish Study Group on Verapamil in Myocardial Infarction. Effect of verapamil on mortality and major events after acute myocardial infarction (the Danish Verapamil Infarction Trial II - DAVIT II). Am J Cardiol. 1990;66:779-785.
22. Brand DA, Newcomer LN, Freiburger A, Tian H. Cardiologists' practices compared with practice guidelines: use of beta-blockade after acute myocardial infarction. J Am Coll Cardiol. 1995;26: 1432-1436.
23. Gersh BJ, Kronmal RA, Schaff HV, Frye RL, Ryan TJ, Mock MB, Myers WO, Athearn MW, Gosselin AJ, Kaiser GC, Bourassa MG, Killip T, and the Participants in the Coronary Artery Surgery Study. Comparison of coronary artery bypass surgery and medical therapy in patients 65 years of age or older. N Engl J Med. 1985;313:217-224.